PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 13, 2004Stroke268 citationsOpen Access

International Comparison of Stroke Cost Studies

View Full Paper
SESilvia EversJSJeroen N. StruijsAAAndré J.H.A. Ament

Key Points

  • This study aims to compare health care expenditures and costs associated with stroke across various countries.
  • Conducted a literature review of stroke cost studies from January 1966 to July 2003.
  • Evaluated methodological and monetary issues using a standardized checklist.
  • Reviewed a total of 25 selected stroke cost studies.
  • Estimated stroke costs across 8 countries are around 3% of total health care expenditures.
  • There is a noted shift from inpatient treatment costs in the first year to outpatient and long-term care costs in later years.
  • Cost considerations for patients and families, as well as comorbidity costs, were largely neglected in the reviewed studies.

Abstract

PURPOSE: With the rapid international spread of interventions, there is a need to understand the economic implications of these changes and to interpret these economic implications on the international level. The purpose of this study is to systematically compare total health care expenditures on stroke, the costs of stroke per capita, and the distribution of stroke costs within different countries, with special attention to the allocation of resources among different health care facilities. METHODS: Studies for this literature review were selected by conducting a literature search from January 1966 to July 2003. Key methodological, country-related, and monetary issues of the selected stroke cost studies were evaluated using a checklist. RESULTS: After selection, 25 stroke cost studies were reviewed. Although the selected cost of illness studies used different methodologies, the estimated expenditures for stroke are approximately similar. The proportion of national health care in the 8 countries studied is unequivocal for the more recent studies, ie, approximately 3% of total health care expenditures. A shift is observed from the inpatient treatment costs (in the first year) toward outpatient treatment and long-term care costs (in the latter years). Furthermore, it is remarkable that in the studies, little attention is paid to costs borne by the patient and family or to the costs of comorbidity. CONCLUSIONS: This study highlights the importance of studying the economic consequences of stroke and of interpreting the results on the international level. The results of stroke cost studies provide insight into the distribution of the costs of stroke and the impact of stroke on the national expenditure on health care.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Evers et al. (2004) studied this question.

synapsesocial.com/papers/6a0eee11950456576347e4b7https://doi.org/10.1161/01.str.0000125860.48180.48
Ask AI
Helpful
Bookmark
Share
View Full Paper